Drug Profile
Research programme: orphan nuclear receptor modulators - Genfit/Bicoll
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bicoll GmbH; Genfit
- Class Small molecules
- Mechanism of Action Orphan nuclear receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation